+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Alpha- Antitrypsin Deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha- Antitrypsin Deficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nosocomial Pneumonia - Pipeline Insight, 2024 - Product Thumbnail Image

Nosocomial Pneumonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Tuberculosis - Pipeline Insight, 2024 - Product Thumbnail Image

Tuberculosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2024 - Product Thumbnail Image

ARDS - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pneumonia, Pneumococcal - Pipeline Insight, 2024 - Product Thumbnail Image

Pneumonia, Pneumococcal - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Interstitial Lung Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Interstitial Lung Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024 - Product Thumbnail Image

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Fungal Pneumonia - Pipeline Insight, 2024 - Product Thumbnail Image

Fungal Pneumonia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Eosinophilic Asthma - Pipeline Insight, 2024 - Product Thumbnail Image

Eosinophilic Asthma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
VAC 18193 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

VAC 18193 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
OZAWADE Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

OZAWADE Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Chronic Obstructive Lung Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Obstructive Lung Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bronchial Dysplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchial Dysplasia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2024 - Product Thumbnail Image

Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more